
Cadila Pharmaceuticals Launches Empadon (Empagliflozin): Ushering a New Era in Diabetes, Heart Failure, and Kidney ...
Cadila Pharmaceuticals, a pioneer in affordable and innovative healthcare solutions, proudly announces the launch of Empadon (Empagliflozin), marking its strategic foray into the transformative SGLT2 inhibitor therapy space. This launch reinforces the …